logo
Share SHARE
FONT-SIZE Plus   Neg

AstraZeneca Says US Court Dismissed Lawsuit Without Prejudice Against FDA

AstraZeneca Plc (AZN,AZN.L) said that the US District Court denied the company's request for a preliminary injunction application against the FDA and dismissed the lawsuit without prejudice.

On March 23, the US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the FDA regarding final marketing approval of generic quetiapine.

Notwithstanding the Court's decision, the company continues to believe strongly in the merits of its position and is evaluating its options.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The European Union's executive arm has ordered the Irish government to recover up to 13 billion euros, or $14.5 billion, in taxes from Apple Inc. The European Commission said it has concluded that Ireland granted the U.S. tech giant undue tax benefits of up to 13 billion euros, which is illegal under EU state aid rules. Shares of Apple are down 1 percent in pre-market activity. Abercrombie & Fitch Co. (ANF) reported Tuesday a wider year-over-year net loss for the second-quarter, hurt by a impairment charge. Net sales for the quarter were down 4%, with comparable sales declined 4%. Quarterly loss was wider than their expectations, but revenues beat their' estimates. The performance of Biotech stocks thus far this month is nothing to write home about, if we were to look at it from the standpoint of the movement of the NYSE Arca Biotechnology Index. A peek at what transpired on the FDA front in August and a preview of what September holds in store for us look pertinent.
comments powered by Disqus
Follow RTT